{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:14:29Z","timestamp":1776899669601,"version":"3.51.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute, National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Health and Human Services"},{"name":"Public Health Service grant"},{"name":"cooperative agreement","award":["5U24CA076518"],"award-info":[{"award-number":["5U24CA076518"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"cooperative agreement","award":["4U10HL069294"],"award-info":[{"award-number":["4U10HL069294"]}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["HHSH250201200016C"],"award-info":[{"award-number":["HHSH250201200016C"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-17-1-2388"],"award-info":[{"award-number":["N00014-17-1-2388"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N0014-17-1-2850"],"award-info":[{"award-number":["N0014-17-1-2850"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010535","name":"Actinium Pharmaceuticals, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amneal Biosciences"},{"DOI":"10.13039\/100016316","name":"Angiocrine Bioscience, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016316","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Atara Biotherapeutics, Inc"},{"DOI":"10.13039\/100001738","name":"Be The Match Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"bluebird bio, Inc"},{"name":"Bristol-Myers Squibb Oncology"},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016318","name":"Cerus Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016318","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chimerix, Inc"},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Gamida Cell Ltd"},{"DOI":"10.13039\/100005564","name":"Gilead Sciences, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HistoGenetics, LLC"},{"name":"Immucor; Incyte Corporation"},{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs, LLC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011096","name":"Jazz Pharmaceuticals, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014561","name":"Juno Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007136","name":"Karyopharm Therapeutics, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014481","name":"Kite Pharma, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014841","name":"Medac, GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014841","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mediware"},{"name":"Merck & Company, Inc"},{"name":"Mesoblast Ltd"},{"name":"Meso Scale Diagnostics, LLC"},{"name":"Millennium Pharmaceuticals"},{"name":"Takeda Oncology Company"},{"DOI":"10.13039\/501100004176","name":"Miltenyi Biotec, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004176","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Marrow Donor Program"},{"name":"Neovii Biotech NA, Inc"},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical Co, Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"PCORI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pharmacyclics, LLC"},{"name":"PIRCHE AG"},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010293","name":"Seattle Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010293","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shire"},{"DOI":"10.13039\/100006399","name":"Spectrum Pharmaceuticals, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015234","name":"Sunesis Pharmaceuticals, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015234","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Orphan Biovitrum AB"},{"DOI":"10.13039\/100011957","name":"Takeda Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017070","name":"Telomere Diagnostics, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017070","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jaad.2019.10.034","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T11:33:59Z","timestamp":1571744039000},"page":"762-772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation"],"prefix":"10.1016","volume":"83","author":[{"given":"Megan M.","family":"Herr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rochelle E.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather R.","family":"Tecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.","family":"Engels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K.","family":"Cahoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoo","family":"Battiwalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary E.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Brazauskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwen E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay M.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.10.034_bib1","unstructured":"D'Souza A, Fretham C. Current uses and outcomes of hematopoietic cell transplantation (HCT): CIBMTR summary slides, 2017. Milwaukee, WI: Center for International Blood & Marrow Transplant Research. Available at: http:\/\/www.cibmtr.org. Accessed July 18, 2018."},{"issue":"10","key":"10.1016\/j.jaad.2019.10.034_bib2","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbmt.2013.07.020","article-title":"Prevalence of hematopoietic cell transplant survivors in the United States","volume":"19","author":"Majhail","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jaad.2019.10.034_bib3","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2019.10.034_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2008-05-158782","article-title":"Solid cancers after allogeneic\u00a0hematopoietic cell transplantation","volume":"113","author":"Rizzo","year":"2009","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jaad.2019.10.034_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone\u00a0marrow transplantation","volume":"336","author":"Curtis","year":"1997","journal-title":"N Engl J Med"},{"issue":"2 Suppl","key":"10.1016\/j.jaad.2019.10.034_bib6","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.bbmt.2011.10.005","article-title":"Subsequent malignant neoplasms after hematopoietic cell transplantation","volume":"18","author":"Socie","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jaad.2019.10.034_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2016.09.005","article-title":"National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the Subsequent Neoplasms Working Group Report","volume":"23","author":"Morton","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jaad.2019.10.034_bib8","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","article-title":"New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors","volume":"21","author":"Baker","year":"2003","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jaad.2019.10.034_bib9","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.bbmt.2014.07.009","article-title":"Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning","volume":"20","author":"Ringden","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.034_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamadermatol.2015.3902","article-title":"Skin cancer risk in hematopoietic stem-cell transplant recipients compared with background population and renal transplant recipients: a population-based cohort study","volume":"152","author":"Omland","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.034_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jaad.2018.01.012","article-title":"Role of graft-versus-host disease in the development of secondary skin cancers in hematopoietic stem cell transplant recipients: a meta-analysis","volume":"79","author":"Rambhia","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2019.10.034_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bmt.2015.63","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation","volume":"50","author":"Inamoto","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jaad.2019.10.034_bib13","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cam4.729","article-title":"Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)","volume":"5","author":"Dyer","year":"2016","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.jaad.2019.10.034_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbmt.2009.09.015","article-title":"The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls","volume":"16","author":"Bishop","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jaad.2019.10.034_bib15","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbmt.2010.10.023","article-title":"Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors","volume":"17","author":"Khera","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaad.2019.10.034_bib16","author":"Noone"},{"issue":"3","key":"10.1016\/j.jaad.2019.10.034_bib17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ije\/dyp166","article-title":"Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls","volume":"38","author":"Chang","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"1","key":"10.1016\/j.jaad.2019.10.034_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamadermatol.2018.3964","article-title":"Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites","volume":"155","author":"Ghiasvand","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"D 24","key":"10.1016\/j.jaad.2019.10.034_bib19","article-title":"Validation of daily erythemal doses from Ozone Monitoring Instrument with ground-based UV measurement data","volume":"112","author":"Tanskanen","year":"2007","journal-title":"J Geophys Res Atmospheres"},{"issue":"5-6","key":"10.1016\/j.jaad.2019.10.034_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/09286586.2018.1501077","article-title":"Ultraviolet radiation and incidence of cataracts in a nationwide US cohort","volume":"25","author":"Delavar","year":"2018","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.jaad.2019.10.034_bib21","series-title":"Cancer Epidemiology and Prevention","first-page":"227","article-title":"Ionizing radiation","author":"Berrington de Gonzalez","year":"2017"},{"issue":"11","key":"10.1016\/j.jaad.2019.10.034_bib22","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/djy052","article-title":"Mutual risks of cutaneous melanoma and specific lymphoid neoplasms: second cancer occurrence and survival","volume":"110","author":"Herr","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"28","key":"10.1016\/j.jaad.2019.10.034_bib23","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1200\/JCO.2014.60.2094","article-title":"Risk factors for melanoma among survivors of non-Hodgkin lymphoma","volume":"33","author":"Lam","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2019.10.034_bib24","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.1401894","article-title":"Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells","volume":"194","author":"Lu","year":"2015","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2019.10.034_bib25","first-page":"22614","article-title":"Regression of cutaneous invasive squamous cell carcinoma in a patient with chronic cutaneous graft versus host disease","volume":"20","author":"Balagula","year":"2014","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.jaad.2019.10.034_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1365-2133.2002.04748.x","article-title":"Naevi in allogeneic bone marrow transplantation recipients: the effect of graft-versus-host disease on naevi","volume":"147","author":"Andreani","year":"2002","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.034_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbmt.2016.09.023","article-title":"The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease","volume":"23","author":"Cooke","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jaad.2019.10.034_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood-2016-08-686659","article-title":"Mechanistic approaches for the prevention and treatment of chronic GVHD","volume":"129","author":"Cutler","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jaad.2019.10.034_bib29","doi-asserted-by":"crossref","first-page":"e95096","DOI":"10.1371\/journal.pone.0095096","article-title":"Risk of melanoma in people with HIV\/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies","volume":"9","author":"Olsen","year":"2014","journal-title":"PLoS One"},{"issue":"7418","key":"10.1016\/j.jaad.2019.10.034_bib30","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.327.7418.794","article-title":"Basal cell carcinoma","volume":"327","author":"Wong","year":"2003","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.jaad.2019.10.034_bib31","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2019.10.034_bib32","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1055-9965.EPI-10-0243","article-title":"Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review","volume":"19","author":"Wheless","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.jaad.2019.10.034_bib33","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2014a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int J Cancer"},{"issue":"9103","key":"10.1016\/j.jaad.2019.10.034_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(97)08496-1","article-title":"Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens","volume":"351","author":"Dantal","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.034_bib35","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/tid.12367","article-title":"Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients","volume":"17","author":"Wojenski","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jaad.2019.10.034_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaad.2018.08.010","article-title":"Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: a systematic review and meta-analysis","volume":"80","author":"Tang","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"10.1016\/j.jaad.2019.10.034_bib37","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/djs298","article-title":"Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study","volume":"104","author":"Watt","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.jaad.2019.10.034_bib38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2005.02.7052","article-title":"Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation","volume":"24","author":"Leisenring","year":"2006","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.jaad.2019.10.034_bib39","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1158\/0008-5472.CAN-16-3291","article-title":"Risk of second malignancies in solid organ transplant recipients who develop keratinocyte cancers","volume":"77","author":"Zamoiski","year":"2017","journal-title":"Cancer Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219329524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219329524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:55:30Z","timestamp":1759272930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219329524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0190962219329524"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.10.034","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.10.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}